One sign you’re living through a golden age is that there’s a lot of gold being tossed around.
Michael Greeley, a venture capitalist at Boston-based Flare Capital Partners, asserts that the Boston area is indeed experiencing such a bounty of ideas when it comes to health care innovation. The amount of money being invested in companies trying to create cancer drugs, apps to treat addiction, and new kinds of health care plans is setting records. According to the data provider CB Insights, roughly $100 billion has been invested in health care-related companies so far this year — topping the record $80 billion that went into the sector in 2020. (Greeley offers his perspective on the latest investment activity on his blog, On the Flying Bridge.)
What is it?
STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis.
Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What’s included?
- Daily reporting and analysis
- The most comprehensive industry coverage from a powerhouse team of reporters
- Subscriber-only newsletters
- Daily newsletters to brief you on the most important industry news of the day
- STAT+ Conversations
- Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
- Exclusive industry events
- Premium access to subscriber-only networking events around the country
- The best reporters in the industry
- The most trusted and well-connected newsroom in the health care industry
- And much more
- Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
Credit: Source link
